The Evan Bray Show - Matthew Kaeberlein - October 15th, 2024

Loading player...
A drug typically prescribed to suppress the immune systems of organ transplant patients is being used by everyday people, now, with the hope of delaying aging and age-related diseases. Dr. Matthew Kaeberlein, CEO of Optispan, an American healthcare technology company, joins Evan to discuss the hype around rapamycin.
15 Oct 2024 1PM English South Africa News Commentary

Other recent episodes

How one Saskatchewan business is really putting safety first!

A Saskatchewan facility is being celebrated for a major safety milestone! AGI’s manufacturing facility in Swift Current has reached three years without a lost-time injury. Shane Moore, AGI Swift Current Operations Manager and Ken Silk, AGI Senior Director Manufacturing Support, join the show to talk about what it takes to…
19 Mar 1PM 11 min